| Similar Articles |
|---|
 |
The Motley Fool
September 11, 2010
Anand Chokkavelu |
How Much of a Bargain Is Johnson & Johnson Stock Right Now? Let's take a look to see how cheap shares of Johnson & Johnson are trading, how consistent its performance has been, and what kind of growth profile it has -- both on an absolute and a relative basis.   |
The Motley Fool
September 12, 2010
Anand Chokkavelu |
How Expensive Is Google Stock Right Now? Let's use some carefully chosen metrics to size up Google's true value. |
The Motley Fool
September 11, 2010
Anand Chokkavelu |
How Much of a Bargain Is Apple Stock Right Now? What can price multiples, consistency of past earnings, and amount of growth expected tell us about Apple's true value? |
The Motley Fool
January 8, 2012
Anand Chokkavelu |
Best Buy's Stock Looks Cheap by the Numbers Let's take a look. |
The Motley Fool
September 10, 2010
Anand Chokkavelu |
How Expensive Is Abbott Laboratories Stock Right Now? Abbott Laboratories has a mixed performance in hitting the ideal targets, but let's see how it compares against some competitors and industry mates. |
The Motley Fool
September 3, 2010
Anand Chokkavelu |
Is Microsoft Stock Cheap Right Now? Let's take a look. |
The Motley Fool
September 17, 2010
Anand Chokkavelu |
How Cheap Is Frontline Stock by the Numbers? Let's see what those numbers can tell us about how cheap oil shipper Frontline might be. |
The Motley Fool
January 16, 2012
Anand Chokkavelu |
Hidden Cheapness in IAC's Numbers? Let's take a look. |
The Motley Fool
September 16, 2010
Anand Chokkavelu |
How Cheap Is Brocade by the Numbers? Brocade is 0 for 4 on hitting the ideal targets, but let's see how it compares against some competitors and industry mates. |
The Motley Fool
September 15, 2010
Anand Chokkavelu |
How Much of a Bargain Is SandRidge Energy Stock Right Now? Let's take a look. |
The Motley Fool
September 10, 2010
Anand Chokkavelu |
How Much of a Bargain Is Home Depot Stock Right Now? Let's take a look. |
The Motley Fool
September 10, 2010
Anand Chokkavelu |
How Cheap Is IBM Stock Right Now? Let's take a look at how cheaply shares of IBM are trading, how consistent its performance has been, and what kind of growth profile it has -- both on an absolute and a relative basis. |
The Motley Fool
January 20, 2012
Anand Chokkavelu |
A Look at AES' Initial Numbers Let's take a look. |
The Motley Fool
September 11, 2010
Anand Chokkavelu |
How Expensive Is Amazon.com Stock Right Now? Let's see what numbers can tell us about how cheap Amazon.com might be. |
The Motley Fool
January 19, 2012
Anand Chokkavelu |
Winnebago's Stock by the Numbers Winnebago wisely keeps a debt-free balance sheet that helps it weather the storms. |
The Motley Fool
September 17, 2010
Anand Chokkavelu |
How Much of a Bargain Is Otter Tail by the Numbers? Let's see what those numbers can tell us about how cheap electric utility and diversified manufacturer Otter Tail might be. |
The Motley Fool
August 30, 2010
Anand Chokkavelu |
How Cheap Is ExxonMobil Stock Right Now? Let's take a look. |
The Motley Fool
January 17, 2012
Anand Chokkavelu |
Are Covanta's Numbers Worth Looking Into? Covanta has a mixed performance in hitting the ideal targets, but let's see how it compares against some competitors and industry mates. |
The Motley Fool
September 2, 2010
Anand Chokkavelu |
Is Pfizer Stock Cheap Right Now? If you find Pfizer's numbers compelling, continue your due diligence. |
The Motley Fool
October 18, 2010
Anand Chokkavelu |
Seagate Technology Looks Very Cheap by the Numbers Let's take a look. |
The Motley Fool
August 13, 2011
Anand Chokkavelu |
RadioShack's Stock Is Cheap Look at what the numbers can tell us about how expensive or cheap RadioShack might be. |
The Motley Fool
September 7, 2010
Anand Chokkavelu |
How Much of a Bargain Is Frontier Communications Right Now? Let's take a look. |
The Motley Fool
January 5, 2012
Anand Chokkavelu |
Can Varian's Stock Be Cheap by the Numbers? Let's take a look. |
The Motley Fool
January 11, 2012
Anand Chokkavelu |
How Pricey Is Goldcorp's Stock by the Numbers? Past growth has been good, but future growth will depend not only on the effectiveness of Goldcorp's spend but also on the price of commodities. |
The Motley Fool
September 17, 2010
Anand Chokkavelu |
How Expensive Is Cirrus Logic Stock by the Numbers? Let's see what the numbers can tell us about how cheap integrated circuit maker Cirrus Logic might be. |
The Motley Fool
September 2, 2010
Anand Chokkavelu |
How Cheap Is General Electric Stock Right Now? Let's use some carefully chosen metrics to size up General Electric's true value. |
The Motley Fool
November 28, 2011
Anand Chokkavelu |
How Reasonable Is Republic Services' Stock by the Numbers? Over the last five years, Republic Services has tallied up five years of positive earnings and five years of positive free cash flow. |
The Motley Fool
September 2, 2010
Anand Chokkavelu |
Is DuPont Stock Cheap Right Now? Here's how DuPont compares it its peers for trailing five-year growth. |
The Motley Fool
September 2, 2010
Anand Chokkavelu |
How Much of a Bargain Is Schlumberger Stock Right Now? Over the past five years, Schlumberger has tallied up 5 years of positive earnings and 5 years of positive free cash flow. |
The Motley Fool
September 14, 2010
Anand Chokkavelu |
How Much of A Bargain Is Kinder Morgan Energy Stock Right Now? Let's take a look. |
The Motley Fool
August 24, 2011
Andrew Tonner |
Does Abbott Laboratories Look Like a Winning Investment? A quick check of their numbers shows us that Abbott Labs looks reasonably attractive. |
The Motley Fool
May 30, 2011
Andrew Tonner |
Does Varian Medical Systems Deserve a Spot in Your Portfolio? Varian looks pretty attractive with above-average return on investment, margins, and fair growth. |
The Motley Fool
December 13, 2011
Dan Caplinger |
Has Boston Scientific Become the Perfect Stock? Since we looked at Boston Scientific last year, the maker of medical devices has gotten up off the mat and quadrupled its score. |
The Motley Fool
January 29, 2009
Brian Orelli |
No Buyer's Remorse at Boston Scientific The pacemakers and defibrillators that Guidant contributed to Boston Scientific's bottom line are still growing strong, but the company had to take a whopping $2.7 billion goodwill writedown because the value of what it purchased has changed. |
The Motley Fool
September 26, 2005
Stephen D. Simpson |
Boston Scientific: Finally Cheap Enough? Could shares of the medical device company now be attractive for long-term investors? |
The Motley Fool
April 29, 2011
Andrew Tonner |
Does Intel Deserve a Spot in Your Portfolio? A quick check of its numbers should help get us started. |
The Motley Fool
February 1, 2010
Brian Orelli |
Now That's Some Expensive Risk Mitigation Boston Scientific avoids a trial -- but at a dear cost. |
The Motley Fool
April 21, 2011
Andrew Tonner |
Does Star Scientific Deserve a Spot in Your Portfolio? A quick check of the consumer products manufacturer's numbers should help get us started. |
The Motley Fool
February 15, 2006
Tim Beyers |
Who's Buying Now? Sometimes, insiders are buying for all the right reasons. Who's buying now? Boston Scientific... Franklin Bank... Fossil... Gartner... iPass... |
The Motley Fool
July 23, 2008
Brian Orelli |
Leaner Boston Scientific Isn't Looking Healthy Investors are rightfully growing weary of Boston Scientific's ability to cut expenses on flat sales, and they send the stock down. |
The Motley Fool
February 5, 2008
Brian Orelli |
Boston Scientific Gets Charged Walloped by charges, Boston Scientific posts a loss for the quarter. |
The Motley Fool
May 25, 2005
Stephen D. Simpson |
Stent Wars 2: The Market-Share Menace The battle for drug-coated stent market share between Johnson & Johnson and Boston Scientific may not be as exciting as watching Obi-Wan Kenobi and Anakin Skywalker fight, but the outcome matters for investors. |
The Motley Fool
August 11, 2010
David Meier |
Does Bill Miller Think Johnson & Johnson Is Attractive? Johnson & Johnson fits Miller's criteria perfectly. It pays a 3.6% dividend that has been growing 11.1%, on average, for the past five years. |
The Motley Fool
June 13, 2006
Jim Mueller |
Foolish Investing and Boston Scientific In having bought Guidant, Boston Scientific might end up paying more than just the price. Investors, take note. |
The Motley Fool
November 11, 2009
Jim Mueller |
This Company Is a Value Stock! Isn't It? A look at Boston Scientific leads to conflicting conclusions. |
The Motley Fool
April 23, 2008
Brian Orelli |
Boston Scientific Gets It Done After a rough 2007, it looks like Boston Scientific is turning itself around from the bottom up. |
The Motley Fool
August 24, 2011
Andrew Tonner |
Does Bristol-Myers Squibb Look Like a Winning Investment? Bristol-Myers, Pfizer, and J&J all look tempting, trading in the mid-teens relative to their earnings. |
The Motley Fool
July 21, 2010
Brian Orelli |
Boston Scientific Bounces When you're as beaten-down as Boston Scientific, you seemingly have nowhere to go but up. There's also bankruptcy, but the beleaguered medical device maker seems far from that -- at least for now. |
The Motley Fool
February 12, 2010
Brian Orelli |
Too Bad It's Not in the "Restructuring" Business Shares of Boston Scientific slipped nearly 10% yesterday, after the company released earnings and guidance for this year. |
The Motley Fool
December 3, 2010
Seth Jayson |
How Boston Scientific May Be Failing You With recent TTM margins all well below historical averages, Boston Scientific has some work to do. |
